|
|
Article: ^sup 18^F-FLT PET in Glioma Proliferation
- Article from:
- The Journal of Nuclear Medicine
- Article date:
- June 1, 2008
- Author:
-
|
Copyright informationCopyright Society of Nuclear Medicine Jun 2008. Provided by ProQuest LLC. (Hide copyright information)
|
Ullrich et al. from the Max Planck Institute for Neurological Research and the Klaus-Joachim Zülch Laboratories (Cologne, Germany) reported in the April 1 issue of Clinical Cancer Research (2008; 14:2049-2055) on a study designed to investigate the relationship between in vivo derived kinetic parameters for ^sup 18^F-fluoiOthymidine (^sup 18^F-FLT) and the proliferation rate measured in vitro by Ki-67 staining in patients with newly diagnosed high-grade gliomas. The study included 13 such patients who underwent ^sup 18^F-FLT PET. ^sup 11^C-methioninc (^sup 11^C-MET) PET. and Tl-, T2-. and gadolinium T1-weighted MR imaging on consecutive days. Tracer kinetic parameters, standardized uptake ...
Related newspaper, magazine, and journal articles:
|